Association between circulating fibroblast growth factor 21, aerobic fitness, and aortic blood pressure in middle-aged and older women-Reference-Cited by-同舟云学术

Association between circulating fibroblast growth factor 21, aerobic fitness, and aortic blood pressure in middle-aged and older women

Published:2019-09-25 Issue:5 Volume:8 Page:195-201
ISSN:2186-8123
Container-title:The Journal of Physical Fitness and Sports Medicine
language:en
Short-container-title:JPFSM

Author:

Matsui Masahiro¹,Kosaki Keisei²³,Akazawa Nobuhiko⁴,Tanahashi Koichiro²,Kuro-o Makoto⁵,Maeda Seiji²

Affiliation:

1. Graduate School of Comprehensive Human Sciences, University of Tsukuba

2. Faculty of Health and Sport Sciences, University of Tsukuba

3. Japan Society for the Promotion of Science

4. Japan Institute of Sport Science

5. Division of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University

Publisher

The Japanese Society of Physical Fitness and Sports Medicine

Link

https://www.jstage.jst.go.jp/article/jpfsm/8/5/8_195/_pdf

Reference40 articles.

1. 1) Itoh N and Ornitz DM. 2011. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149: 121-130. doi: 10.1093/jb/mvq121.

2. 2) Nishimura T, Nakatake Y, Konishi M and Itoh N. 2000. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492: 203-206.

3. 3) Cuevas-Ramos D, Almeda-Valdes P, Aguilar-Salinas CA, Cuevas-Ramos G, Cuevas-Sosa AA and Gomez-Perez FJ. 2009. The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism. Curr Diabetes Rev 5: 216-220.

4. 4) Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE and Kharitonenkov A. 2008. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149: 6018-6027. doi: 10.1210/en.2008-0816.

5. 5) Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK and Veniant MM. 2009. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58: 250-259. doi: 10.2337/db08-0392.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating leukocyte cell-derived chemotaxin 2 and fibroblast growth factor 21 are negatively associated with cardiorespiratory fitness in healthy volunteers;Applied Physiology, Nutrition, and Metabolism;2023-06-01

2. Relationship between physical activity and circulating fibroblast growth factor 21 in middle-aged and older adults;Experimental Gerontology;2020-11